Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Pharmalucence, Inc.
WARNING LETTER
•Pharmalucence, Inc.•April 30, 2008

Pharmalucence, Inc. – FDA Warning Letter, Apr 30, 2008

Record Details

An FDA inspection of Pharmalucence, Inc. from April 7-30, 2008, revealed significant deviations from cGMP regulations (21 CFR Parts 210 and 211) for finished pharmaceuticals, rendering their drug products adulterated.

Key violations include: 1. **Sterilization Process Deficiencies (21 CFR § 211.113(b)):** Failure to validate bacterial filtration retention for multiple aseptically filled products (e.g., CIS-PYRO, AN-DTPA, CIS-Sulfur Colloid), observed poor aseptic technique, inadequate validation of steam sterilization cycles (e.g., lack of steam penetration studies, no justification for worst-case loads, unvalidated load configurations), insufficient environmental and personnel monitoring (e.g., improper air sampler placement, unvalidated multi-location testing), un-evaluated microbiological burden from manual aseptic connections, and incomplete airflow pattern testing studies. 2. **Inadequate Quality Control Investigations (21 CFR § 211.192):** Failure to thoroughly investigate environmental/personnel monitoring excursions (e.g., lack of root cause analysis, delayed initiation) and insufficient investigation into sterility testing issues for Iobenguane Sulfate I 131 (MIBG) Injection. 3. **Container Suitability (21 CFR § 211.94(c)):** Unvalidated dep

Company
Pharmalucence, Inc.
Inspection date
April 30, 2008
Product type
Drugs
Office
New England District Office
People
  • John R. Marzilli
  • Glenn Alto
  • Amber G. Wardwell (Compliance Officer)
View Company Profile

ID · 1f3a4751-ee1e-47fa-93d6-8cd442935736

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.113(b)21 CFR 211.19221 CFR 211.94(c)21 CFR 211.28(a)21 CFR 211.5821 CFR 211.165(b)21 CFR 211.165(e)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmalucence, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.